Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
CannaRoyalty Corp
CNNRF | US
4.03
USD-0.02
-0.58%
CNNRF | US
About CannaRoyalty Corp
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
21/10/2024
Close
4.03
Open
4.01
High
4.03
Low
4.00
View Less
CNNRF | US
Risk
27.4
Sharpe
0
Luna's Score
43/100
Recommendation
Sell
Luna says (CNNRF | US)
What's Working
Good Dividend Yield (2% <= Dividend Yield <= 8%)
Low Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
Strong Operating Margin (> 25%)
What's not Working
Price Below SMA10D
Microcap (<300M USD)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
27.9%1 month
27.4%3 months
42.8%6 months
37.3%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.97
Debt to equity
1.42
Debt to assets
0.57
Ent. to EBITDA
37.69
Ent. to rev.
10.44
PEG
-
Other Fundamentals
EBITDA
-
MarketCap
82.64M
MarketCap(USD)
82.64M
Div. yield
6.24
Op. margin
63.54
Erngs. growth
-73.80
Rev. growth
-11.40
Ret. on equity
-0.23
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
0.25
Range1M
0.40
Range3M
0.74
Volumes: Market Activity
Rel. volume
0.05
Price X volume
2.02K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 37.69 | - | Expensive |
| Ent. to Revenue | 10.44 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 0.97 | 15.55 | Cheaper |
| Dividend Yield | 6.24 | - | Leader |
| Std. Deviation (3M) | 42.75 | - | Lower Risk |
| Debt to Equity | 1.42 | -1.23 | Expensive |
| Debt to Assets | 0.57 | 0.25 | Expensive |
| Market Cap | 82.64M | - | Emerging |
